波形蛋白(VIM)多克隆抗體
Polyclonal Antibody to Vimentin (VIM)
- 編號UPAB040Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB040Hu01-波形蛋白(VIM)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Rattus norvegicus (Rat,大鼠), Cavia (Guinea pig ,豚鼠), Canis familiaris; Canine (Dog,犬), Sus scrofa; Porcine (Pig,豬), Bos taurus; Bovine (Cattle,牛), Capra hircus; Caprine (Goat,山羊), Equus caballus; Equine (Horse,馬), Chicken (Gallus,雞)
- 應(yīng)用WB; IHC; ICC/IF
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 299 ¥ 697 ¥ 996 ¥ 2490 ¥ 9960
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對VIM的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別VIM。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunofluorescence: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
URPB040Hu02 | 波形蛋白(VIM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UAPB040Hu01 | 波形蛋白(VIM)活性蛋白 | Cell?culture;?Activity?Assays. |
URPB040Hu01 | 波形蛋白(VIM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UEPB040Hu61 | 波形蛋白(VIM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UEPB040Hu62 | 波形蛋白(VIM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UPAB040Hu02 | 波形蛋白(VIM)多克隆抗體 | IHC; ICC/IF |
UPAB040Hu01 | 波形蛋白(VIM)多克隆抗體 | WB; IHC; ICC/IF |
ULAB040Hu71 | 波形蛋白(VIM)多克隆抗體(生物素標記) | WB |
UMAB040Hu24 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
UMAB040Hu25 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
UMAB040Hu21 | 波形蛋白(VIM)單克隆抗體 | WB; IHC |
UMAB040Hu23 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
UMAB040Hu27 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
UMAB040Hu22 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
UFAB040Hu02 | 抗波形蛋白(VIM)單克隆抗體 | FCM |
UFAB040Hu06 | 抗波形蛋白(VIM)單克隆抗體 | FCM |
UFAB040Hu04 | 抗波形蛋白(VIM)單克隆抗體 | FCM |
UFAB040Hu08 | 抗波形蛋白(VIM)單克隆抗體 | FCM |
USEB040Hu | 波形蛋白(VIM)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
ULMB040Hu | 波形蛋白(VIM)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
UKSB040Hu01 | 波形蛋白(VIM)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Cancer?Epidemiology,?Biomarkers?& Prevention | Aberrant Vimentin Methylation Is Characteristic of Breast Cancer [pubmed:22315367] |
Scientific Reports | Glyoxalase?1-knockdown?in?human?aortic?endothelial?cells - effect on the?proteome?andendothelial?function?estimates. [pubmed:27898103] |
Journal of?Proteomics | HtrA3 is a cellular partner of cytoskeleton proteins and TCP1α chaperonin [Pubmed:29477555] |
Journal of Biological Chemistry | Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy [Pubmed: 31511328] |
American Journal of Transplantation | Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts [Pubmed: 31729155] |
Lung | Is Vimentin the Cause or Effect of Obstructive Sleep Apnea Development? [Pubmed: 32088750] |
Cell Biol Toxicol | ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer [33566221] |
CELL BIOLOGY AND TOXICOLOGY | Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence [33758996] |
Comparison of Vimentin Levels Between Preeclamptic and Normotensive Pregnant Women [] | |
Advanced glycation end-products associate with podocytopathy in type II diabetic patients [] | |
Non-POU Domain-Containing Octamer-Binding (NONO) Protein Stability Regulated by PIN1 is Crucial for Breast Cancer Tumorigenicity Via the MAPK/β?… [] |
留言咨詢